Biolife Sciences Inc の最大収益セグメントは Banking and Related Activities で、最新の利益発表における収益は 31,116,000,000 です。地域別に見ると、Mexico が Biolife Sciences Inc の主要市場であり、収益は 31,116,000,000 です。
Biolife Sciences Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Biolife Sciences Incの純損失は$0です。
Biolife Sciences Incに負債はありますか?
はい、Biolife Sciences Incの負債は1です。
Biolife Sciences Incの発行済株式数は何株ですか?
Biolife Sciences Incの総発行済株式数は57.13株です。
主要データ
前終値
$0.0001
始値
$0.0001
当日レンジ
$0.0001 - $0.0001
52週レンジ
$0.0001 - $0.0001
取引高
911
平均取引高
0
配当利回り
--
1株当たり利益(TTM)
-2.14
時価総額
$318.3K
BLFEとは何ですか?
Bio Life Sciences, Inc. provides healthcare, beauty, food and beverage industry services. The company is headquartered in Henderson, Nevada. The company went IPO on 2005-04-25. The firm's core business develops, licenses and distributes antimicrobial products and disruptive technology. Its solutions include Copper-Infused Textiles and Copper Infused Fabric Pots. Its BioLife antimicrobial copper fabric filter acts as a layer of protection by trapping in bacteria and releasing clean air. BioLife Antimicrobial Copper-Infused Textiles kill viruses and bacteria on contact through preventative clothing and textiles designed to inhibit virus and bacteria reproduction and cross contamination before it starts. Its BioLife Copper Infused Fabric Pots provides healthier plant growth. The copper infusion allows the plants that grow in the pots with additional protections from harmful microbes which can harm plants.